Has the FDA been playing too fast & loose with new drug approvals? -- Which of the COVID-era changes to the American workplace will be sticking around -- Why COVID knocks out your sense of smell

There was a lot of controversy when the FDA approved an expensive, and possibly ineffective drug for Alzheimer's patients last year. Turns out this has become a trend---the FDA has been busy greenlighting several contested drugs under so-called "accelerated approval"---we'll take a closer look.
And which of the COVID-induced changes to the American workplace will be sticking around for good........and which ones will be tossed out with your old face masks?

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

There was a lot of controversy when the FDA approved an expensive, and possibly ineffective drug for Alzheimer's patients last year. Turns out this has become a trend---the FDA has been busy greenlighting several contested drugs under so-called "accelerated approval"---we'll take a closer look.

And which of the COVID-induced changes to the American workplace will be sticking around for good........and which ones will be tossed out with your old face masks?

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices